Statements of Cash Flows - USD ($)	5 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021
Cash Flows from Operating Activities:
Net income (loss)	$ (2,237)	$ 8,502,767
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Formation costs paid by Sponsor in exchange for issuance of Class B ordinary shares	2,116
Warrant issuance costs		980,011
Change in fair value of warrants		(10,642,498)
Trust interest income		(35,110)
Changes in current assets and current liabilities:
Prepaid expenses		(106,900)
Accrued offering costs and expenses		463,204
Due to related parties	122	(122)
Net cash used in operating activities	1	(838,648)
Cash Flows from Investing Activities:
Marketable securities held in Trust Account		(169,175,000)
Net cash used in investing activities		(169,175,000)
Cash Flows from Financing Activities:
Proceeds from Initial Public Offering		167,500,000
Payment of underwriting fees		(3,350,000)
Proceeds from private placements		6,975,000
Proceeds from Sponsor loan	111,286
Repayment of promissory note to related party		(300,000)
Payments of offering costs	(89,855)	(541,645)
Net cash provided by financing activities	21,431	170,283,355
Net change in cash	21,432	269,707
Cash, beginning of the year		21,432
Cash, end of the year	21,432	291,139
Supplemental Disclosure of Non-cash Financing Activities:
Deferred underwriting commissions charged to additional paid in capital		5,862,500
Initial value of Class A ordinary shares subject to possible redemption		151,224,541
Reclassification of offering costs related to public shares		(9,105,839)
Subsequent measurement of Class A ordinary shares subject to redemption		27,056,298
Subsequent measurement of Class A ordinary shares subject to redemption (interest earned on trust account)		35,110
Forfeiture of founder shares		156
Issuance of representative shares		10
Initial classification of warrant liabilities		16,962,761
Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares	22,884
Deferred offering costs paid by Sponsor loan	188,714
Accrued deferred offering costs	$ 30,252